Amryt Pharma Plc

Amryt Pharma (AMYT)

Company name:Amryt Pharma Plc
EPIC:AMYTTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BKLTQ412
Market Segment:ASQ1Share Type:DE
WWW Address: 6P
 Price Price Change [%] Bid Offer Open High Low Volume
 143.00 0.0 [0.00] 151.00 170.00 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 457.11 319.66 -0.08 -73.79 - - - 190.00 - 135.50

Amryt Pharma Key Figures

(at previous day's close)
Market Cap.457.11m
Shares In Issue319.66m
Prev. Close143.00
PE Ratio- 
Dividend Yield-%
EPS - basic-73.79p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-9.93p
Return On Equity (ROE)-50.68%
Operating Margin-114.86%
PEG Factor- 
EPS Growth Rate-816.84%
Dividends PS Growth Rate-%
Net Debt285.86m
Gross Gearing75.80%
Quick Assets87.68m
Net Working Capital39.79m
Intangibles / Fixed Assets98.62%
Turnover PS15.39p
Pre-Tax Profit PS-17.67p
Retained Profit PS-17.35p
Cash PS17.80p
Net Cash PS-8.73p
Net Tangible Asset Value PS *-66.83p
Net Asset Value PS34.24p
Spread19.00 (11.18%) 

Amryt Pharma Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Amryt Pharma Historic Returns

Sorry No Data Available

Amryt Pharma Key Management Ratios

Amryt Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.51 
Tobin's Q Ratio (excl. intangibles)5.36 
Dividend Yield-%
Market-to-Book Ratio4.18 
Price-to-Pre-Tax Profit PS-8.09 
Price-to-Retained Profit PS-8.24 
Price-to-Cash Flow PS-14.41 
Price-to-Sales PS9.29 
Price-to-Net Tangible Asset Value PS-2.14 
Price-to-Cash PS8.03 
Net Working Capital PS12.45 
Price Pct to Working Capital PS11.49%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Amryt Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio70.21%
Debt-to-Equity Ratio2.36 
Debt-to-Equity Ratio (excl. Intgbl)-1.21 
Debt-to-Equity Market Value0.56 
Net Gearing63.22%
Net Gearing (excl. Intangibles)221.39%
Gross Gearing75.80%
Gross Gearing (excl. Intangibles)265.45%
Gearing Under 1 Year18.75%
Gearing Under 1 Year (excl. Intgbl)65.68%
(Liquidity Ratios)
Net Working Capital to Total Assets8.80%
Current Ratio1.47 
Quick Ratio (Acid Test)1.03 
Liquidity Ratio0.67 
Cash & Equiv/Current Assets45.66%
(Solvency Ratios)
Enterprise Value658.16m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.75 
Total Debt/Sales6.97 
Total Debt/Pre-Tax Profit-6.07 
Total Debt342.75m
Total Debt/Net Current Assets8.61%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs2 
Beta (60-Mnth)Beta (36-Mnth)

Amryt Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-15.38%
Return On Assets (ROA)-18.33%
Net Profit Margin-112.75%
Assets Turnover0.16 
Return On Equity (ROE)-50.68%
Return On Investment (ROI)-22.44%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-112.75%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.78 
Fixed Assets Turnover0.22 
Current Assets Turnover0.60 
Net Working Capital Turnover 
Inventory Turnover2.16 
(Other Operating Ratios)
Total Assets-to-Sales6.15 
Debt Collection Period154.22Days

Amryt Pharma Dividends

Sorry No Data Available

Amryt Pharma Fundamentals

 31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
pre tax profit-7.80-577.65%-26.14-204.54%-25.74-178.09%-66.76-114.86%m
attributable profit-7.80-577.65%-26.11-204.37%-25.78-178.34%-65.54-112.75%m
retained profit-7.80-577.65%-26.11-204.37%-25.78-178.34%-65.54-112.75%m
eps - basic-4.78 -11.72 -9.38 -86.00 
eps - diluted-4.78 -11.72 -9.38 -86.00 
dividends per share- - - - 

Amryt Pharma Balance Sheet

 31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
 31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
fixed assets fixed assets1.181.81%1.161.45%0.961.36%3.040.57%m
intangibles intangibles52.5280.45%52.6165.68%52.7074.59%381.7771.45%m
fixed investments fixed investments--%--%0.130.18%2.310.43%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.771.18%1.081.35%1.872.64%43.628.16%m
debtors debtors2.543.89%4.735.90%5.187.33%36.396.81%m
cash & securities cash & securities8.2712.67%20.5125.61%9.8113.89%67.2312.58%m
creditors - short creditors - short3.555.44%9.8012.23%10.5314.90%100.2118.75%m
creditors - long creditors - long28.7043.96%48.4160.44%63.3589.67%304.8157.04%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves33.0450.60%21.8927.33%-3.23-4.57%129.3224.20%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Amryt Pharma Cash Flow Statement

31 Dec 2016 (EUR)31 Dec 2017 (EUR)31 Dec 2018 (EUR)31 Dec 2019 (EUR)
Operating CF-6.11-11.86-13.07-37.50m
Pre-Financing CF-3.65-12.18-13.28-13.07m
Retained CF8.1012.24-10.7056.00m

Amryt Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220625 08:28:44